Equity · Healthcare
DCTH
NASDAQDelcath Systems (DCTH)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 425.5M USD
- P/E (TTM)
- 76.4
- Revenue, year to Dec 2025
- 85.2M USD
- EPS, diluted, year to Dec 2025
- 0.07 USD
- 52-week range
- 8.19 USD – 16 USD
- Avg volume
- 88.2K
as of Jul 24, 2026
Have Delcath Systems (DCTH) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, no Delcath Systems insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).
Form 4, 90 days to 11 Nov 2026, newest Form 4 filing 13 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 13 Oct 2026 | Rosalind Advisors, Inc.Director | Other | 31,129 |
Which funds hold Delcath Systems (DCTH)?
9 of the 45 institutional funds we track reported a Delcath Systems position for the quarter ended 30 Jun 2026 — a combined 15.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Held (±25%) | 566,371 | 7.1M USD | −3.7% |
| Marshall Wace | Held (±25%) | 218,963 | 2.8M USD | +14.3% |
| AQR Capital Management | Added | 172,993 | 2.2M USD | +439.0% |
| Man Group | Added | 128,495 | 1.6M USD | +25.7% |
| D. E. Shaw & Co. | New position | 57,894 | 729K USD | |
| Balyasny Asset Management | Trimmed | 28,468 | 358K USD | −26.1% |
| Citadel Advisors | Trimmed | 15,043 | 189K USD | −80.5% |
| Tudor Investment Corp | Trimmed | 12,042 | 152K USD | −45.3% |
| Two Sigma Investments | New position | 10,054 | 127K USD | |
| Renaissance Technologies | Exited |
Have members of Congress traded Delcath Systems (DCTH)?
The most recent congressional trade disclosed in Delcath Systems is a sale by Roger Marshall (senate, KS), dated 09 Jun 2017.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 09 Jun 2017 | Roger Marshallsenate · Republican–KS | Sale | 1K USD–15K USD | 423 days |
What has been filed or recorded for Delcath Systems (DCTH)?
The filings we hold for Delcath Systems, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 197 shares | 3K USD notional · 0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.17 USD | |
| 30 Sep 2026 | Financials | Total assets | 149.1M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 133.5M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.07 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.03 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.07 USD | |
| 31 Dec 2025 | Financials | Revenue | 85.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 2.7M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.07 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.02 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.07 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.03 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.93 USD |
What do people ask about Delcath Systems (DCTH)?
What is Delcath Systems’ market cap?425.5M
Delcath Systems is worth 425.5M USD by market value as of 24 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Delcath Systems’ P/E ratio?76.4
Delcath Systems has a price-to-earnings ratio of 76.4, as of 24 Jul 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Delcath Systems’ revenue?85.2M
Delcath Systems reported revenue of 85.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Delcath Systems insiders bought or sold shares recently?1 filing
In the 90 days to 11 Nov 2026, no Delcath Systems insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4). See Insiders
Which funds own Delcath Systems?9 of 45
9 of the 45 funds we track reported a Delcath Systems position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Marshall Wace and AQR Capital Management. See Funds
Have members of Congress traded Delcath Systems?1 trade
Yes. 1 trade in Delcath Systems appears in the congressional disclosures we hold: a sale by Roger Marshall (Senate, KS) dated 9 Jun 2017, filed 6 Aug 2018. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Delcath Systems last report earnings?0.17
Delcath Systems last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.17 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Roger Marshall: U.S. Senate Photographic Studio, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings